SYNT vs. VCT, SCPA, ESNT, TET, ZTF, IOF, HAYD, DCTA, WCH, and ITX
Should you be buying Synthomer stock or one of its competitors? The main competitors of Synthomer include Victrex (VCT), Scapa Group (SCPA), Essentra (ESNT), Treatt (TET), Zotefoams (ZTF), Iofina (IOF), Haydale Graphene Industries (HAYD), Directa Plus (DCTA), Wilmcote Holdings plc (WCH.L) (WCH), and Itaconix (ITX). These companies are all part of the "specialty chemicals" industry.
Synthomer vs. Its Competitors
Victrex (LON:VCT) and Synthomer (LON:SYNT) are both small-cap basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, media sentiment, analyst recommendations, institutional ownership and profitability.
Victrex currently has a consensus price target of GBX 1,170, indicating a potential upside of 49.81%. Synthomer has a consensus price target of GBX 225, indicating a potential upside of 139.62%. Given Synthomer's stronger consensus rating and higher probable upside, analysts plainly believe Synthomer is more favorable than Victrex.
In the previous week, Synthomer had 5 more articles in the media than Victrex. MarketBeat recorded 8 mentions for Synthomer and 3 mentions for Victrex. Synthomer's average media sentiment score of 0.37 beat Victrex's score of 0.25 indicating that Synthomer is being referred to more favorably in the news media.
Victrex has a net margin of 10.81% compared to Synthomer's net margin of -4.40%. Victrex's return on equity of 6.67% beat Synthomer's return on equity.
Victrex pays an annual dividend of GBX 60 per share and has a dividend yield of 7.7%. Synthomer pays an annual dividend of GBX 25 per share and has a dividend yield of 26.6%. Victrex pays out 170.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Synthomer pays out -50.1% of its earnings in the form of a dividend. Synthomer is clearly the better dividend stock, given its higher yield and lower payout ratio.
Victrex has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500. Comparatively, Synthomer has a beta of 1.79, suggesting that its stock price is 79% more volatile than the S&P 500.
97.1% of Victrex shares are held by institutional investors. Comparatively, 43.8% of Synthomer shares are held by institutional investors. 1.6% of Victrex shares are held by insiders. Comparatively, 28.0% of Synthomer shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Victrex has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Victrex, indicating that it is currently the more affordable of the two stocks.
Summary
Synthomer beats Victrex on 10 of the 18 factors compared between the two stocks.
Get Synthomer News Delivered to You Automatically
Sign up to receive the latest news and ratings for SYNT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SYNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Synthomer Competitors List
Related Companies and Tools
This page (LON:SYNT) was last updated on 7/5/2025 by MarketBeat.com Staff